GPT-Rosalind (OpenAI) vs Gemma 4 (Google)
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Gemma 4 (Google)
Google DeepMind's open-weights model family -- multimodal, 256K context, runs on edge devices
| Category | GPT-Rosalind (OpenAI) | Gemma 4 (Google) |
|---|---|---|
| Ease of Use | 3.0 | 7.0 |
| Output Quality | 9.0 | 8.0 |
| Value | 7.0 | 10.0 |
| Features | 8.0 | 8.0 |
| Overall | 6.8 | 8.3 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Gemma 4 (Google) |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Benchmark Head-to-Head
Gemma 4 31B benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks
| Benchmark | Description | Score |
|---|---|---|
| MMLU | Knowledge across 57 subjects | 83% |
| GPQA Diamond | Graduate-level science questions | 84.3% |
| AIME 2026 | 89.2% | |
| HumanEval | Python code generation | 85% |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
- ✓Higher output quality (9 vs 8)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Gemma 4 (Google) if...
- ✓Easier to use (7 vs 3)
- ✓Better value for money (10/10)
- ✓Has a free tier
Developers and businesses who need a permissively licensed multimodal LLM they can self-host or fine-tune. Especially good for multilingual use cases and on-device deployment.
Visit Gemma 4 (Google)Our Verdict
Gemma 4 (Google) is the clear winner here with 8.3/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Gemma 4 (Google) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.